Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2011

May 2, 2011

32227_dirs_2011-05-02_32337cd9-a398-4f09-a2f1-1bb06fe92033.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NEOGENOMICS INC (NGNM.OB)
CIK: 0001077183
Period of Report: 2011-05-02

Reporting Person: SMITS MARK W (Chief Commercial Officer)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6667 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock option(Right to Buy) $1.02 2015-08-30 Common Stock (425000) Direct

Footnotes

F1: On August 30, 2010 Mr. Smits was granted an option to purchase 425,000 shares. The first date options became exercisable and vested was August 30, 2010. The options are a combination of time based and performance options. Within 60 days of this filing 45,000 options are exercisable and vested.